[The immunologic behavior of carcinoma in situ of the bladder].
A report is given on 13 patients with c. i. s. of the bladder, which are examined in vivo and in vitro with respect to their immune reactivity. In skin tests with 5 recall antigens and the primary antigen DNFB there is no difference as compared with a control group of 29 patients. In an EM test 11 of the 13 patients with c. i. s. reacted with histospecific lymphocyte sensitisation, 10 out of 13 positive results were obtained with the antigen HEP. These findings support the current view of c. i. s. of the bladder as the first stage of a malign degeneration.
D000328:Adult; D000368:Aged; D000941:Antigens / Q000276:immunology; D002278:Carcinoma in Situ / Q000276:immunology* / Q000601:surgery; D006801:Humans; D007428:Intradermal Tests; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000276:immunology* / Q000601:surgery
D000941:Antigens
Zum immunologischem Verhalten beim Carcinoma in situ der Harnblase.